Funds and ETFs Neuronetics, Inc.

Equities

STIM

US64131A1051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-02-23 pm EST 5-day change 1st Jan Change
3.29 USD +0.30% Intraday chart for Neuronetics, Inc. +6.13% +13.45%
Neuronetics, Inc. is a commercial stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The Company intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The Company sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
3.29 USD
Average target price
6.667 USD
Spread / Average Target
+102.63%
Consensus
  1. Stock
  2. Equities
  3. Stock Neuronetics, Inc. - Nasdaq
  4. Funds and ETFs Neuronetics, Inc.
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer